Bausch Lomb Corporation is an eye health company in Canada and internationally. The company is headquartered in Vaughan, Canada.
| Revenue (TTM) | $5.21B |
| Gross Profit (TTM) | $3.16B |
| EBITDA | $724.00M |
| Operating Margin | 4.74% |
| Return on Equity | -3.28% |
| Return on Assets | 1.41% |
| Revenue/Share (TTM) | $14.70 |
| Book Value | $17.90 |
| Price-to-Book | 0.89 |
| Price-to-Sales (TTM) | 1.09 |
| EV/Revenue | 2.015 |
| EV/EBITDA | 16.43 |
| Quarterly Earnings Growth (YoY) | -88.60% |
| Quarterly Revenue Growth (YoY) | 9.40% |
| Shares Outstanding | $356.54M |
| Float | $44.77M |
| % Insiders | 87.55% |
| % Institutions | 11.01% |
Volatility is currently contracting